Novartis Pharmaceuticals Corporation (NVS) Drug Afinitor(R) First to Shrink SEGA Brain Tumors in Children and Adults With Tuberous Sclerosis
6/7/2010 8:48:25 AM
More...
|
Data at American Society of Clinical Oncology Show Promise of Novartis Pharmaceuticals Corporation (NVS) Drugs For Patients With Life-Threatening Diseases Like CML, Multiple Myeloma and Breast Cancer
6/2/2010 9:58:15 AM
More...
|
US Affiliate of Novartis Pharmaceuticals Corporation (NVS) Strongly Disputes Claims of Past Discrimination in the US
5/19/2010 11:25:31 AM
More...
|
Polyphor Announces First PEMfinder(R) collaboration with Big Pharma, Novartis Pharmaceuticals Corporation (NVS)
5/6/2010 10:52:14 AM
More...
|
Novartis Vaccines & Diagnostics, Inc. (NVS), Novartis Pharmaceuticals Corporation (NVS) to Pay $72.5 Million to Settle US False Claims
5/5/2010 7:11:25 AM
More...
|
Novartis Pharmaceuticals Corporation (NVS) Receives US FDA Approval for Zortress(R) to Prevent Organ Rejection in Adult Kidney Transplant Recipients
4/22/2010 6:39:06 AM
More...
|
IntelliPharmaCeutics Announces Settlement for its Generic Version of Focalin XR(R)
3/12/2010 8:21:43 AM
More...
|
US FDA Approves Novartis Pharmaceuticals Corporation (NVS) (JOBS) Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
8/17/2009 6:40:58 AM
More...
|
FDA Approves Novartis Pharmaceuticals Corporation (NVS)'s (JOBS) Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
7/21/2009 8:01:53 AM
More...
|
FDA Approves Novartis Pharmaceuticals Corporation (NVS)'s (JOBS) Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
5/1/2009 7:38:52 AM
More...
|
|